NEWS
View news from our Featured Companies.
Aytu BioPharma Reports Record Quarterly Revenue and Positive Adjusted EBITDA in First Quarter of Fiscal Year 2023
Record Quarterly Net Revenue of $27.7 Million Driven by 34% Growth in Rx SegmentPositive Adjusted EBITDA for the Quarter of $1.4 MillionLeadership Changes Implemented to Focus on Commercial OperationsCompany to Host Conference Call Today at 4:30pm ETENGLEWOOD, CO /...
INVO Bioscience Reports Third Quarter 2022 Financial Results
Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla., Nov. 14, 2022 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell®...
SenesTech Announces Third Quarter 2022 Financial Results
Product Sales up 57% year-over-year PHOENIX, Nov. 14, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats,...
SenesTech Announces Appointment of Vector and Pest Control Industry Veteran Joel Fruendt as Chief Executive Officer
PHOENIX, Nov. 14, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the...
S&W Announces First Quarter Fiscal 2023 Financial Results
LONGMONT, Colo., Nov. 14, 2022 -- S&W Seed Company (Nasdaq: SANW) today announced financial results for the three months ended September 30, 2022. Q1 2023 Financial and Recent Highlights Revenue for the first quarter of fiscal 2023 was $19.9 million, an increase...
Scientific Industries to Report First Quarter Fiscal Year 2023 Financial Results on November 14, 2022
Investor Call to be held November 15th at 4:30 PM Eastern TimeBOHEMIA, NY / November 11, 2022 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today it will file a Form...
ChromaDex Reports FDA’s Conclusion that Nicotinamide Mononucleotide (NMN) May Not Be Sold or Marketed as a Dietary Supplement in the United States
U.S. FDA declares NMN ingredient may not be sold or marketed as a dietary supplement in the U.S. since first investigated as a drug LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), a global bioscience company dedicated to healthy aging, today announced that on November 4,...
InfuSystem to Participate at 13th Annual Craig-Hallum Alpha Select Conference on November 17, 2022
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2022
Conference Call Scheduled for Tuesday, November 22, 2022 at 9:00 AM ETPORTLAND, Maine, Nov. 10, 2022 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven and...
INVO Bioscience to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET SARASOTA, Fla., Nov. 10, 2022 -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide...
Mogo Reports Third Quarter 2022 Financial Results
Q3 revenue of $17.3 million, up 12% year over year Ended quarter with cash, digital assets & investments of $106.0 million1 Company announces comprehensive restructuring plan to accelerate path to profitability Mogo reports in Canadian dollars and in accordance...
LiqTech International Announces Third Quarter 2022 Financial Results
BALLERUP, Denmark, Nov. 10, 2022 -- LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced its financial results for the third quarter of 2022. Q3...
SenesTech to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
Financial results to be released before market open; Conference call to be conducted at 11:00 am ET PHOENIX, Nov. 9, 2022 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its third quarter 2022, ended September 30, 2022, before the market open on...
LiqTech Further Strengthens Commercial Capabilities with Appointment of Tobias Madsen
BALLERUP, Denmark, Nov. 9, 2022 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems, today announced the appointment of Mr. Tobias Baldrian Madsen as Head of...
PolyPid Provides Corporate Update and Reports Third Quarter 2022 Financial Results
Company Intends to Meet with U.S. and EU Regulatory Authorities to Discuss Data from SHIELD I Phase 3 Study and Regulatory Pathway for D-PLEX100 in First Quarter of 2023 Implemented a Cost Reduction Plan, Including a 20% Decrease in Headcount Across All Departments...
Kiora Pharmaceuticals Provides 3rd Quarter 2022 Business and Financial Update; Dosing of KIO-301 in Phase 1 Trial for Retinitis Pigmentosa to Begin Before Year’s End
Salt Lake City, Utah--(November 9, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today is providing a business update and reporting financial results for the three and nine months ended September 30, 2022.Management Discussion: "We're...
S&W Seed Company to Report First Quarter Fiscal Year 2023 Financial Results on Monday, November 14, 2022
Conference call to be conducted on Monday, November 14, 2022, at 11:00AM ET LONGMONT, Colo., Nov. 8, 2022 -- S&W Seed Company (Nasdaq: SANW) will report financial results for its first quarter of fiscal year 2023, ended September 30, 2022, on Monday, November 14,...
LiqTech Receives Wastewater Treatment System Order for Metal Processing Industry
BALLERUP, Denmark, Nov. 8, 2022 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems, today announced the receipt of an order for a wastewater treatment system for...
InfuSystem Reports Third Quarter 2022 Financial Results
Record Net Revenues of $27.3 million and Record ITS revenues of $17.4 million Operating Income increased $1.3 million and Net Income increased $0.9 million ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU), ("InfuSystem" or the "Company"), a...
Aytu BioPharma to Report First Quarter Fiscal 2023 Financial Results on November 14, 2022
ENGLEWOOD, CO / November 7, 2022 / Aytu BioPharma, Inc. (the Company or "Aytu") (Nasdaq:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused prescription drugs and cost-effective consumer health solutions, will report...
Mogo Schedules Q3 2022 Earnings Conference Call
VANCOUVER, British Columbia - Mogo Inc. (TSX:MOGO) (NASDAQ:MOGO) ("Mogo" or the "Company"), a digital payments and financial technology company, today announced it will hold a conference call and webcast to discuss its Q3 2022 financial results on Thursday, November...
Shuttle Pharmaceuticals Engages Theradex Oncology in Preparation for Clinical Study
ROCKVILLE, Md., Nov. 3, 2022 -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT) while reducing its side...
LiqTech Launches Enhanced Aqua Solution® Membrane for Commercial Pool and Spa Market
BALLERUP, Denmark, Nov. 3, 2022 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems, today announced the launch of an enhanced Aqua Solution® membrane, based on...
IRADIMED CORPORATION Announces Third Quarter 2022 Financial Results
Revenue was $13.4 million and increased by 23%Operating income was $4.1 million and increased 32%GAAP diluted EPS was $0.27 and increased by 35%Announces fourth quarter 2022 financial guidance WINTER SPRINGS, Fla., Nov. 03, 2022 -- IRADIMED CORPORATION (the "Company")...
InfuSystem to Report Third Quarter 2022 Financial Results on November 8, 2022
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...